Cargando…

The Network of Non-coding RNAs in Cancer Drug Resistance

Non-coding RNAs (ncRNAs) have been implicated in most cellular functions. The disruption of their function through somatic mutations, genomic imprinting, transcriptional and post-transcriptional regulation, plays an ever-increasing role in cancer development. ncRNAs, including notorious microRNAs, h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Corrà, Fabio, Agnoletto, Chiara, Minotti, Linda, Baldassari, Federica, Volinia, Stefano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123370/ https://www.ncbi.nlm.nih.gov/pubmed/30211115 http://dx.doi.org/10.3389/fonc.2018.00327

Ejemplares similares

SNPs and Somatic Mutation on Long Non-Coding RNA: New Frontier in the Cancer Studies?
por: Minotti, Linda, et al.
Publicado: (2018)

Profiling of the Predicted Circular RNAs in Ductal In Situ and Invasive Breast Cancer: A Pilot Study
por: Galasso, Marco, et al.
Publicado: (2016)

Screen for MicroRNA and Drug Interactions in Breast Cancer Cell Lines Points to miR-126 as a Modulator of CDK4/6 and PIK3CA Inhibitors
por: Baldassari, Federica, et al.
Publicado: (2018)

UC.183, UC.110, and UC.84 Ultra-Conserved RNAs Are Mutually Exclusive with miR-221 and Are Engaged in the Cell Cycle Circuitry in Breast Cancer Cell Lines
por: Corrà, Fabio, et al.
Publicado: (2021)

Heterogeneous expression of EPCAM in human circulating tumour cells from patient-derived xenografts
por: Agnoletto, Chiara, et al.
Publicado: (2018)

The network of non-coding RNAs and their molecular targets in breast cancer
por: Crudele, Francesca, et al.
Publicado: (2020)

Heterogeneity in Circulating Tumor Cells: The Relevance of the Stem-Cell Subset
por: Agnoletto, Chiara, et al.
Publicado: (2019)

Mitochondria dysfunction in circulating tumor cells
por: Agnoletto, Chiara, et al.
Publicado: (2022)

The Role of Non-Coding RNAs in Breast Cancer Drug Resistance
por: Tian, Jin-hai, et al.
Publicado: (2021)

Inverse Impact of Cancer Drugs on Circular and Linear RNAs in Breast Cancer Cell Lines
por: Terrazzan, Anna, et al.
Publicado: (2023)

Loss of miR-204 expression is a key event in melanoma
por: Galasso, Marco, et al.
Publicado: (2018)

Non-Coding RNAs and Resistance to Anticancer Drugs in Gastrointestinal Tumors
por: Hahne, Jens C., et al.
Publicado: (2018)

The Non-Coding RNAs Inducing Drug Resistance in Ovarian Cancer: A New Perspective for Understanding Drug Resistance
por: Li, Gaofeng, et al.
Publicado: (2021)

Long Non-Coding RNAs: Role in Testicular Cancers
por: Bresesti, Chiara, et al.
Publicado: (2021)

Long Non-coding RNAs Involved in Resistance to Chemotherapy in Ovarian Cancer
por: Abildgaard, Cecilie, et al.
Publicado: (2020)

The Role of Long Non-coding RNAs in Immunotherapy Resistance
por: Zhou, Yuwen, et al.
Publicado: (2019)

Non-Coding RNAs Regulate the Resistance to Anti-EGFR Therapy in Colorectal Cancer
por: Chu, Jinjin, et al.
Publicado: (2022)

Non-coding RNAs: a key to future personalized molecular therapy?
por: Galasso, Marco, et al.
Publicado: (2010)

The Role of Non-Coding RNAs in the Sorafenib Resistance of Hepatocellular Carcinoma
por: Hu, Xinyao, et al.
Publicado: (2021)

Editorial: Non-Coding RNAs in Breast Cancer
por: Zhang, Wenwen, et al.
Publicado: (2021)

The Molecular Networks of microRNAs and Their Targets in the Drug Resistance of Colon Carcinoma
por: Crudele, Francesca, et al.
Publicado: (2021)

The Role of microRNAs, Long Non-coding RNAs, and Circular RNAs in Cervical Cancer
por: Tornesello, Maria Lina, et al.
Publicado: (2020)

Non-coding RNAs: Emerging Regulators of Sorafenib Resistance in Hepatocellular Carcinoma
por: Lai, Yongting, et al.
Publicado: (2019)

The Role of Long Non-Coding RNAs in Thyroid Cancer
por: Peng, Xuejiao, et al.
Publicado: (2020)

Roles of Non-Coding RNAs in Cervical Cancer Metastasis
por: Cheng, Tanchun, et al.
Publicado: (2021)

Non-Coding RNAs in Colorectal Cancer: Their Functions and Mechanisms
por: Jia, Zimo, et al.
Publicado: (2022)

Editorial: Long non-coding RNAs in lung cancer
por: Malapelle, Umberto, et al.
Publicado: (2022)

Editorial: The role of non-coding RNAs in gastrointestinal cancer
por: Kumar, Divya P., et al.
Publicado: (2022)

Regulation of autophagy by non-coding RNAs in gastric cancer
por: Wang, Zijian, et al.
Publicado: (2022)

MicroRNAs, long non-coding RNAs, and circular RNAs and gynecological cancers: focus on metastasis
por: Rezaee, Aryan, et al.
Publicado: (2023)

Corrigendum: Non-coding RNAs: Emerging Regulators of Sorafenib Resistance in Hepatocellular Carcinoma
por: Lai, Yongting, et al.
Publicado: (2020)

Role of Long Non-Coding RNAs in Conferring Resistance in Tumors of the Nervous System
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2021)

Non-Coding RNAs in Invadopodia: New Insights Into Cancer Metastasis
por: Li, Feiya, et al.
Publicado: (2021)

Non-coding RNA in cancer drug resistance: Underlying mechanisms and clinical applications
por: Zhou, Xuehao, et al.
Publicado: (2022)

Dysregulation of Transglutaminase type 2 through GATA3 defines aggressiveness and Doxorubicin sensitivity in breast cancer
por: Aguiari, Gianluca, et al.
Publicado: (2022)

Role of Non-coding RNAs in the Pathogenesis of Endometriosis
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2020)

Non-coding RNAs in Pancreatic Ductal Adenocarcinoma
por: Gong, Ruining, et al.
Publicado: (2020)

Long Non-coding RNAs in Myeloid Malignancies
por: Zimta, Alina-Andreea, et al.
Publicado: (2019)

Non-Coding RNAs Participate in the Pathogenesis of Neuroblastoma
por: Rezaei, Omidvar, et al.
Publicado: (2021)

m6A Modification in Non-Coding RNA: The Role in Cancer Drug Resistance
por: Chen, Chen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_elk0t9ahtdihsmot4fgebjd5qk